Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Tumour Diseases”

15,301 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 15,301 results

Not applicableNot Yet RecruitingNCT06710093
What this trial is testing

Power of Liquid Biopsy Tracking in Immunotherapy Treated Stage IV Melanoma

Who this might be right for
Metastatic Melanoma
Royal Marsden NHS Foundation Trust 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07802184
What this trial is testing

GnP Combined With SHR-1701 and Apatinib as First-Line Treatment for Locally Advanced or Metastatic PDAC

Who this might be right for
Locally Advanced Pancreatic CancerMetastatic Pancreatic Cancer
West China Hospital 45
Post-approval studies (Phase 4)UnknownNCT01023633
What this trial is testing

OPTIMOX1 in Chinese mCRC Patients

Who this might be right for
Colorectal Cancer
Nanjing Medical University 300
Testing effectiveness (Phase 2)Looking for participantsNCT07058948
What this trial is testing

Spatially Fractionated Radiotherapy Combined With Immunotherapy for Advanced Solid Tumors

Who this might be right for
Solid CancersRadiotherapyImmune Checkpoint Inhibitor+1 more
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00169208
What this trial is testing

Fludarabine, Mitoxantrone and Rituximab in Relapsed or Primary Failing Advanced Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Follicular Lymphoma
Lymphoma Study Association 50
Testing effectiveness (Phase 2)UnknownNCT03636308
What this trial is testing

Nab-paclitaxel Plus S-1(AS) Versus Nab-paclitaxel Plus Gemcitabine(AG) in Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Peking University 40
Early research (Phase 1)Study completedNCT01065025
What this trial is testing

Open Label, Dose Escalation Trial of Oral Eg5 Kinesin-spindle Inhibitor 4SC-205 in Patients With Advanced Malignancies

Who this might be right for
Advanced and Incurable Solid TumorsMalignant Lymphomas
4SC AG 60
Early research (Phase 1)Looking for participantsNCT05410717
What this trial is testing

CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
Stage IV Ovarian CancerTestis Cancer, RefractoryEndometrial Cancer Recurrent+1 more
Second Affiliated Hospital of Guangzhou Medical University 200
Large-scale testing (Phase 3)Study completedNCT00080340
What this trial is testing

Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Carcinoma
Telik 520
Large-scale testing (Phase 3)UnknownNCT00541021
What this trial is testing

Gemcitabine With or Without Sorafenib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Institut Paoli-Calmettes 104
Testing effectiveness (Phase 2)Study completedNCT01728233
What this trial is testing

Dacomitinib (PF-00299804) in Advanced/Metastatic Squamous Cell Carcinoma of the Penis

Who this might be right for
Penile NeoplasmsCarcinoma, Squamous Cell
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 32
Large-scale testing (Phase 3)Study completedNCT01671449
What this trial is testing

S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Min-Hee Ryu 338
Early research (Phase 1)Ended earlyNCT00311558
What this trial is testing

Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or Myeloma

Who this might be right for
Cancer
The Cleveland Clinic 18
Testing effectiveness (Phase 2)Study completedNCT03128008
What this trial is testing

Locally Advanced NSCLC Hyperfractionated RT

Who this might be right for
Carcinoma, Non Small Cell Lung (NSCLC)
Duke University 10
Early research (Phase 1)Study completedNCT04328740
What this trial is testing

Phase 1 Study of Oral TP-1454

Who this might be right for
Advanced Solid TumorAnal Cancer
Sumitomo Pharma America, Inc. 31
Early research (Phase 1)Study completedNCT01445405
What this trial is testing

Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer

Who this might be right for
Carcinoma, SquamousHead and Neck CancerOral Cancer+2 more
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Looking for participantsNCT07103395
What this trial is testing

A Study Evaluating Neoadjuvant Chemotherapy, Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade in Patients With Locally Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer (NSCLC)
Sun Yat-sen University 56
Testing effectiveness (Phase 2)WithdrawnNCT05809895
What this trial is testing

Phase II Study Evaluating the Efficacy and Safety of Ociperlimab in Combination With Tislelizumab and Chemotherapy as First-line Treatment for Participants With Advanced Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Ended earlyNCT00452075
What this trial is testing

Erlotinib as First-line Treatment of Advanced Non-small Cell Lung Cancer (NSCLC) for Patients Unfit for Chemotherapy

Who this might be right for
Non Small Cell Lung Cancer
Rigshospitalet, Denmark 24
Testing effectiveness (Phase 2)Looking for participantsNCT06634875
What this trial is testing

Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)

Who this might be right for
Colorectal Cancer Metastatic
Buzzard Pharmaceuticals 20
Next Page